Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety Psychedelics biotech Cybin (NYSE:CYBN) and UK-based Small Pharma (OTC:DMTTF) announced their definitive arr
BenzingaSep 5, 2023 10:07 ET
EXCLUSIVE: Psychedelics Co. Closes $7.5M Financing - Here's Its Secret To Raising Millions In A Tough Environment
In the bustling heart of Miami, amidst the buzz of the Benzinga Cannabis and Psychedelics Capital Conference, a pivotal conversation ignited a partnership destined to revolutionize the world of wellne
BenzingaSep 1, 2023 12:19 ET
Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist Johns Hopkins University academics received a boost in funding thanks to the recently launched Roland R. Griffith
BenzingaMay 15, 2023 17:30 ET
Delix Inks Deal With Cellectricon; Psyched Wellness Partners With Spacestation
Delix Nabs 2 New Partners Neuroscience company Delix Therapeutics is partnering with Sweden-based Cellectricon and New York-based Expressive Neuroscience. The goal is to expedite Delix's drug developm
Benzinga Real-time NewsFeb 16, 2023 13:53 ET
Psychedelics Update: MDMA Export, 3D Farm, Recovery Center Reopens, Mushroom Extraction & E-Commerce
Health Canada Oks Clinical-Grade MDMA Export To UK Life sciences psychedelics company PharmAla Biotech Holdings Inc. and its manufacturing partners received a Health Canada export permit for no less t
Benzinga Real-time NewsJan 24, 2023 14:07 ET
Legal Mushroom Products From Amanita Muscaria Shipped To 37 US States
Canadian-based producer of mushroom-derived health supplements Psyched Wellness Ltd. (OTCQB:PSYCF) has successfully completed the production and delivery of customers' pre-orders of its Amanita muscar
Benzinga Real-time NewsNov 3, 2022 19:38 ET
Amanita Muscaria Mushroom-Based Products Now Offered Online By Psyched Wellness
Canadian life sciences company Psyched Wellness Ltd. (OTCQB:PSYCF), producer and distributor of functional health products derived from Amanita Muscaria, is launching an online store. The company's go
Benzinga Real-time NewsJun 15, 2022 09:08 ET
EXCLUSIVE: Psyched Wellness CEO Breaks Down Mushroom Strategy, From 'Alice In Wonderland' To The Checkout Aisle
Psyched Wellness Ltd (OTCQB:PSYCF) plans to begin selling a psychoactive mushroom extract this summer that's never been scheduled as a drug in the U.S. It's derived from amanita muscaria, an instantly
Benzinga Real-time NewsApr 19, 2022 16:50 ET
Psyched Wellness CEO Buys This Many Shares In The Open Market
Jeffrey Stevens, the CEO and co-founder of Psyched Wellness (OTCQB:PSYCF), has bought 321,000 shares of the company in the open market at CA$0.125 per share for a total cost of of CA$40,125 (around $3
Benzinga Real-time NewsApr 19, 2022 11:05 ET
Psyched Wellness Ltd. (CNSX:FIOR) Director Jeff Stevens Purchases 321,500 Shares
Psyched Wellness Ltd. (CNSX:FIOR – Get Rating) Director Jeff Stevens bought 321,500 shares of the business's stock in a transaction dated Thursday, April 14th. The shares were acquired at an average
ETF Daily NewsApr 16, 2022 13:08 ET
Core One Labs Begins Trading On OTCQB
Under the CLABF symbol, psychedelics-oriented company Core One Labs (OTCQB:CLABF) started trading on the OTCQB Venture Market. The company's CEO, Joel Shacker, commented: "Upgrading to the OTCQB is a
Benzinga Real-time NewsApr 6, 2022 14:20 ET
No Data
No Data